Viewing Study NCT00034866

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:16 PM
Ignite Modification Date: 2026-02-08 @ 2:31 AM
Study NCT ID: NCT00034866
Status: COMPLETED
Last Update Posted: 2005-09-20
First Post: 2002-05-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals
Sponsor: Boehringer Ingelheim
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV View
None treatment experienced View
None Boehringer View
None tipranavir View
None ritonavir View